Transendocardial autologous bone marrow in myocardial infarction induced heart failure, two-year follow-up in an open-label phase I safety study (the TABMMI study)

EuroIntervention

Volumn 7, Issue 7, 2011, Pages 805-812

  De La Fuente, Luis M ^a,b   Stertzer, Simon H ^c   Argentieri, Julio ^a,b   Peñaloza, Eduardo ^a,b   Koziner, Benjamin ^a,b   Rouy, Didier ^d   Altman, Peter A ^d  

^a Instituto Argentino de Diagnostico y Tratamiento   (Argentina)

^b Clinica y Maternidad Suizo Argentina   (Argentina)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d BioCardia Inc   (United States)

Author keywords

Catheters; Cell therapy; Heart failure; Transplantation

Indexed keywords

HEART ENZYME;

ABDOMINAL PAIN; ADULT; ANGINA PECTORIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW BIOPSY; CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TOLERANCE; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOLTER MONITORING; HUMAN; MALE; MONONUCLEAR CELL; OPEN STUDY; PHASE 1 CLINICAL TRIAL; PHLEBITIS; SAFETY; SYNCOPE; TRANSENDOCARDIAL AUTOLOGOUS BONE MARROW TRANSPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 82655181526     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I7A127     Document Type: Article

References (23)

1. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, Miura T, Matsuzaki M, Esato K. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J. 2001;65:845-847.
2. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 2003;361:45-46. (Pubitemid 36050962)
3. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. 2004;44:1690-1699. (Pubitemid 39369805)
4. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141-148. (Pubitemid 38891685)
5. Schachinger V, Tonn T, Dimmeler S, Zeiher AM. Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat Clin Pract Cardiovasc Med. 2006;3 Suppl 1:S23-28.
6. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367:113-121. (Pubitemid 43077127)
7. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J. 2005;39:150-158. (Pubitemid 41657525)
8. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294-2302. (Pubitemid 36578498)
9. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 2003;361:47-49. (Pubitemid 36050963)
10. Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, Baffour R, Waksman R, Weissman NJ, Cerqueira M, Leon MB, Epstein SE. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol. 2003;41:1721-1724. (Pubitemid 36584242)
11. de la Fuente LM, Stertzer SH, Argentieri J, Penaloza E, Miano J, Koziner B, Bilos C, Altman PA. Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study). Am Heart J. 2007;154:79 e71-77.
12. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JW. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003;107:2290-2293. (Pubitemid 36578497)
13. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 2005;102:11474-11479. (Pubitemid 41153844)
14. Kumar A. Assessment of safety, accuracy and human CD34+ cell retention after intramyocardial injections with a helical needle catheter in a porcine model. Paper presented at: American College of Cardiology Annual Scientific Session, 2009; Orlando.
15. Ramshorst JV, Bax JJ, Beeres SLMA, Dibbets-Schneider P, D. Roes SD, Stokkel MPM, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ, Atsma DE. Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia, A Randomized Controlled Trial. JAMA. 2009;301:1997-2004.
16. FDA MAUDE Report Number 2029046-2008-00030, Cytori Precise Study.
17. SEC Accession No. 0001193125-10-153479, 2010-07-02. Aldagen S-1/A 1 ds1a.htm FORM S-1 AMENDMENT NO. 4.
18. Losordo DW, Henry TD, Davidson C, Lee JS, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker J, Povsic TJ, Harrington RA, Schatz RA, the ACT34-CMI Investigators. Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina. Circ Res. 2011;109:351-52.
19. van der Vleuten PA, Nijveldt R, Tan E-S, Tio RA, van Rossum AC, Zijlstra F: Value and limitations of electromechanical endocardial mapping in the assessment of global and regional left ventricular function and transmural extent of infarction: a comparison with cardiovascular magnetic resonance. EuroIntervention. 2010;6:616-622.
20. Williams AR, Zambrano JP, Rodriguez J, Guerra D, Bonny G, McNiece I, Hare JH, Heldman AW. Merged Three Dimensional Cardiac MRI with Electroanatomical Mapping to Guide Transendocardial Injections of Mesenchymal Stem Cells, Abstract 15947, American Heart Association Scientific Sessions, 2010.
21. Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long-term survival after heart failure: a contemporary population-based perspective. Arch intern med. 2007;167:490-496. (Pubitemid 46425662)
22. Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JW, Capewell S, McMurray JJ. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119:515-523.
23. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation. 2008;118:2057-2062.